News for Clinuvel Pharmaceuticals Limited (CUV.AX)

The Telecommunication sector was the biggest loser, down 1.5%, followed by Industrials, down 1.3% and Discretionary, down 1.1%.

Australia stocks lower at close of trade; S&P/ASX 200 down 0.95%

CLINUVEL files Canadian New Drug Submission for SCENESSE ® in EPP

Start Time: 04:00 January 1, 0000 4:35 AM ETClinuvel Pharmaceuticals Limited (OTCPK:CLVLY)Q4 2024 Earnings Conference CallAugust 29, 2024, 04:00 AM...

The following slide deck was published by Clinuvel Pharmaceuticals Limited in conjunction with their 2024 Q4 earnings call.

Australia stocks lower at close of trade; S&P/ASX 200 down 0.33%

The sellers finally stepped in this week to push the All Ordinaries Index down more than 1%. I say 'finally' because markets don’t climb indefinitely without resistance from sellers. It had been almost four weeks since some meaningful selling on our market.

The ASX200 dipped slightly on Friday but finished the first week of the financial year in positive territory, with a 0.7 per cent gain.

Specialty pharmaceutical group Clinuvel Pharmaceuticals (ASX: CUV) has received promising outcomes from the final set of results from a study evaluating

The ASX200 was down 0.15% in lunchtime trades, nearly crossing into the green at 12 O Clock Sydney time before paring gains. Healthcare was in front, up 0.52% – partially driven by strong results from Clinuvel. Materials and Financials were the top draggers on the bourse on Friday in contrast to Thursday – that comes despite a rally in coal stocks and a rebound in the iron ore price.

Afamelanotide in fair-skinned Parkinson's patients

Australia stocks higher at close of trade; S&P/ASX 200 up 0.77%

In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024.

Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Q2 2023 Earnings Call Transcript February 22, 2024 2:00 AM ETCompany ParticipantsVerity Wai-Smith - Monsoon...

The ASX200 has closed the day trading flat. The sectors were split, with utilities in front, up more than 2 per cent.

Clinuvel Pharmaceuticals Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net income was AUD 10.94 million compared to AUD 11.39...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.51% to 6925.50.

Australia stocks lower at close of trade; S&P/ASX 200 down 0.20%

Australia stocks higher at close of trade; S&P/ASX 200 up 0.19%